What is the ticker symbol for Conatus Pharmaceuticals?
Conatus Pharmaceuticals trades on the NASDAQ under the ticker symbol "CNAT." What is Conatus Pharmaceuticals' stock price today? One share of CNAT stock can currently be purchased for approximately $0.23. How much money does Conatus Pharmaceuticals make?
What is Conatus Pharmaceuticals Inc's (cnat) Q1 earnings results?
Conatus Pharmaceuticals Inc (NASDAQ:CNAT) issued its quarterly earnings results on Friday, May, 1st. The biotechnology company reported ($0. 10) earnings per share (EPS) for the quarter, hitting the Thomson Reuters' consensus estimate of ($0. 10). Conatus Pharmaceuticals had a negative net margin of 52.
Will Conatus Pharmaceuticals (cnat) outperform or underperform the S&P 500?
MarketBeat's community ratings are surveys of what our community members think about Conatus Pharmaceuticals and other stocks. Vote “Outperform” if you believe CNAT will outperform the S&P 500 over the long term. Vote “Underperform” if you believe CNAT will underperform the S&P 500 over the long term. You may vote once every thirty days.
Is Conatus Pharmaceuticals's P/E ratio good or bad?
Only 15.20% of the stock of Conatus Pharmaceuticals is held by institutions. The P/E ratio of Conatus Pharmaceuticals is -0.77, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
See more
How were Conatus Pharmaceuticals' earnings last quarter?
Conatus Pharmaceuticals Inc (NASDAQ:CNAT) posted its earnings results on Friday, May, 1st. The biotechnology company reported ($0.10) earnings per...
Who are Conatus Pharmaceuticals' key executives?
Conatus Pharmaceuticals' management team includes the following people: Dr. Steven J. Mento , Co-Founder, Pres, CEO & Director (Age 67) Dr. Keit...
Who are some of Conatus Pharmaceuticals' key competitors?
Some companies that are related to Conatus Pharmaceuticals include Aerovate Therapeutics (AVTE) , Verona Pharma (VRNA) , Ocular Therapeutix (OCU...
What other stocks do shareholders of Conatus Pharmaceuticals own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Conatus Pharmaceuticals investors own include KNOT Offshor...
What is Conatus Pharmaceuticals' stock symbol?
Conatus Pharmaceuticals trades on the NASDAQ under the ticker symbol "CNAT."
What is Conatus Pharmaceuticals' stock price today?
One share of CNAT stock can currently be purchased for approximately $2.38.
How much money does Conatus Pharmaceuticals make?
Conatus Pharmaceuticals (NASDAQ:CNAT) has a market capitalization of $78.94 million and generates $21.72 million in revenue each year.
How many employees does Conatus Pharmaceuticals have?
Conatus Pharmaceuticals employs 30 workers across the globe.
What is Conatus Pharmaceuticals' official website?
The official website for Conatus Pharmaceuticals is www.conatuspharma.com .
Signals & Forecast
Support, Risk & Stop-loss
There are mixed signals in the stock today. The Conatus Pharmaceuticals Inc. stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average.
Is Conatus Pharmaceuticals Inc. stock A Buy?
Conatus Pharmaceuticals Inc. finds support from accumulated volume at $0.23 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
Insiders are positive buying more shares than they are selling in Conatus Pharmaceuticals Inc
Conatus Pharmaceuticals Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.
About Conatus Pharmaceuticals Inc
In the last 100 trades there were 9.92 million shares bought and 1.3 million shares sold. The last trade was done 397 days ago by Daniels Moya who bough 100 thousand shares. The large amount of stocks bought compared to stocks sold indicate that the insiders believe there is a potential good upside.
Golden Star Signal
Conatus Pharmaceuticals Inc., a biotechnology company, focuses on the development and commercialization of novel medicines to treat liver diseases in the United States.
Top Fintech Company
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
When will Canaan release its results?
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
How much did Canaan gain in October?
(NASDAQ: CAN) ("Canaan" or the "Company"), a leading high-performance computing solutions provider, today announced that it plans to release its third quarter 2021 financial results before the market opens on Tuesday, November 16, 2021.
What is Canaan Inc?
Shares of Canaan (NASDAQ: CAN) gained 40.3% in October, according to data from S&P Global Market Intelligence. Canaan provides specialized hardware for the mining of cryptocurrencies, and bullish momentum in the crypto space typically helps push the stock higher. The price per Bitcoin token surged roughly 48.7% last month, helping the cryptocurrency mining specialist's share price post big gains over the stretch.
How much can Canaan repurchase?
Canaan Inc. (NASDAQ: CAN) ("Canaan" or the "Company"), a leading high-performance computing solutions provider, today announced that it has secured a follow-on purchase order from HIVE Blockchain Technologies Ltd. (TSX.V: HIVE; NASDAQ: HIVE) ("HIVE"), for 6,500 units of its next-generation Avalon Bitcoin mining machines.
Is Canaan stock trading lower?
(NASDAQ: CAN) ("Canaan" or the "Company"), a leading high-performance computing solutions provider, today announced that its board of directors has authorized a share repurchase program under which the Company may repurchase up to US$20 million worth of its outstanding (i) American depositary shares ("ADSs"), each representing 15 Class A ordinary shares, and/or (ii) Class A ordinary shares over the next 12 months starting from September 20, 2021.
What is the CAN symbol?
Canaan Inc. (NASDAQ: CAN) share s are trading significantly lower Friday amid a decrease in the price of Bitcoin (CRYPTO: BTC) and Ethereum (CRYPTO: ETH). The price of Bitcoin and several other cryptocurrencies drop after China's Central Bank banned all crypto transactions and vowed to stop illegal crypto mining. The stock could also be trading lower in sympathy with other Chinese companies amid continued regulatory concerns following proposed oversight of the gaming sector in Macau. Regulatory a
What is the P/E ratio of Canaan?
Canaan trades on the NASDAQ under the ticker symbol "CAN."
Where is Canaan located?
The P/E ratio of Canaan is 17.38, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 16.23.
Is there enough data for Canaan?
It is also involved in the assembly of system products; and supply chain and distribution of system products. The company has a strategic cooperation with Northern Data AG in the areas of artificial intelligence development, blockchain technology, and datacenter operations. The company was founded in 2013 and is based in Hangzhou, the People's Republic of China.
Does Canaan pay dividends?
There is not enough analysis data for Canaan.
Who is the CEO of Cango?
Canaan does not currently pay a dividend.
What is Cango Inc?
Joining us today are Mr. Jiayuan Lin , Chief Executive Officer and Mr. Yongyi Zhang, Chief Financial Officer of the company. With that said, I am now turning the call over to Mr. Jiayuan Lin, CEO of Cango.
What is Cango Auto View?
Cango Inc. (NYSE: CANG) ("Cango" or the "Company"), a leading automotive transaction service platform in China, today announced that its board of directors has authorized a new share repurchase program (the "New Share Repurchase Program") under which the Company may repurchase up to US$50 million worth of its outstanding (i) ...
